PatientsVille.com Logo

BRONCHITIS and Seroquel

PatientsVille

BRONCHITIS Symptoms and Causes

Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of Bronchitis: acute and chronic.

Most cases of acute Bronchitis get better within several days. But your cough can last for several weeks after the infection is gone.

The same viruses that cause colds and the flu often cause acute Bronchitis. These viruses spread through the air when people cough, or though physical contact (for example, on unwashed hands). Being exposed to tobacco smoke, air pollution, dusts, vapors, and fumes can also cause acute Bronchitis. Less often, bacteria can also cause acute Bronchitis.

To diagnose acute Bronchitis, your health care provider will ask about your symptoms and listen to your breathing. You may also have other tests.

Treatments include rest, fluids, and aspirin (for adults) or acetaminophen to treat fever. A humidifier or steam can also help. You may need inhaled medicine to open your airways if you are wheezing. Antibiotics won't help if the cause is viral. You may get antibiotics if the cause is bacterial.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for BRONCHITIS

BRONCHITIS treatment research studies

Seroquel clinical trials, surveys and public health registries


Find Drug Side Effect reports



Seroquel Side Effects

Diabetes Mellitus (6103)
Type 2 Diabetes Mellitus (3575)
Insomnia (2241)
Pancreatitis (1939)
Blood Cholesterol Increased (1705)
Weight Increased (1696)
Obesity (1197)
Diabetes Mellitus Inadequate Control (1084)
Diabetic Ketoacidosis (1083)
Depression (1046)
Hyperglycaemia (1037)
Diabetic Neuropathy (1010)
Somnolence (997)
Anxiety (972)
Malaise (971)
Off Label Use (948)
Feeling Abnormal (830)
Blood Triglycerides Increased (806)
Suicidal Ideation (805)
Diabetic Coma (803)
Convulsion (757)
Death (753)
Neuropathy Peripheral (744)
Tardive Dyskinesia (696)
Dizziness (683)
Type 1 Diabetes Mellitus (667)
Hyperlipidaemia (662)
Chest Pain (641)
Hypertension (632)
Fall (631)
Fatigue (612)
Headache (611)
Overdose (594)
Suicide Attempt (564)
Back Pain (547)
Bipolar Disorder (519)
Nausea (492)
Agitation (488)
Tremor (449)
Dyspnoea (437)
Confusional State (432)
Loss Of Consciousness (403)
Vomiting (395)
Mental Disorder (383)
Blood Glucose Increased (382)
Abdominal Pain (378)
Cardiac Disorder (373)
Cerebrovascular Accident (370)
Asthenia (368)
Aggression (359)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

i losing weight doctor say i might have bonchitis

After taking 300 mgm a day of seroquel, I gained 30 lbs over a period of 3 months with all the symptoms of metabolic syndrome. Now I am unable to lose that weight even though I no longer take the medicati9on

After taking Seroquel for about two weeks, I came down with quite serious laryngitis. I've had it for about a week and it is not getting any better. I don't have a cold or sore throat and can't think of any other reason for this. Could this be cau

Check out my med list; kind like a handbook isn't it?

Doing range of motion exercises on the neck with the head is an excellent way of treating cronic insomonia. >:o O:-)

HELLO TO ALL, I was diagnosed with bronchitis 2 weeks ago took a 7 day antibiotic stared feeling a lot better 2weeks after and now i'm sick all over again runny nose congested lungs feel like their boiling inside me coughing up flame but c

Hello, after xray report says normal size cardiac silhouette. bronchitic change seen both lungs. please advice

I also had to increase the weight for my pendulum exercises to make easier to adjust my shoulder. :)

I also had to raise my arms up and down behind my head in order to adjust the top of my neck.

I am a 20 year old female with bronchitis. A 9mm lung nodule was found on my xray. I have smoked very FEW times. In the past 3 weeks I have lost my voice multiple times, and have a had a pretty bad cough. Other symptoms that could possibly be related

i have bronchitis problem, doctor prescribed me zanocin 400mg , i have bowel irritation, little drowsiness

Advair... This was in thesummer of 2004. I had walking pnemonia. Advaid made it worse. I started getting headaches, I couldn't breath and developed bronchitis I coughed all the time. After taking it and for the next four years,I w

After taking the tablets two days, starting seeing blood in urine, by 3rd day, urine was nothing but blood. I was give this for bronchitis

DO NOT TAKE THIS MEDICATION, YOU CAN DIE.... THIS SHOULD BE TAKEN OFF i AM 27 YEARS OLD I TOOK THIS BECAUSE MY DOCTOR SAID I MIGHT BE GETTING BRONCHITIS, 5-10 MINUTES AFTER I TOOK IT, I STARTED SHAKING, I COULDN'T BREATH, I COUNDN'T MOVE, AND I HAD

Has anyone else suffered from Atenelol induced Asthama and Bronchitis?

HELLO TO ALL, I was diagnosed with bronchitis 2 weeks ago took a 7 day antibiotic stared feeling a lot better 2weeks after and now i'm sick all over again runny nose congested lungs feel like their boiling inside me coughing up flame but c

Hello, I have been diagnosed with bronchitis. Dr. prescribed Azithromycin in 08/21/2010 (250 mg) 6 doses-five days. today is 09/10/2010, and i still experiencing some of the side effects

Hi Every Body, Likewise others, i would also like to share my bad experience withTivanic. I was suffering from Bronchitis, which had prolonged and eventually My physician has to prescribe me Tivanic. 1st 2 days were normal, but then I had

I am a 20 year old female with bronchitis. A 9mm lung nodule was found on my xray. I have smoked very FEW times. In the past 3 weeks I have lost my voice multiple times, and have a had a pretty bad cough. Other symptoms that could possibly be related

I am a 31 year old female. I weigh 125 lbs. I took Enbrel on and off for about 3 years for chronic psoriasis. Towards the end of my last treatment and since, I have been diagnosed with chronic accute bronchitis, chronic

BRONCHITIS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Pharmacokinetic Study Comparing Topical, Rectal, and Oral Quetiapine
Conditions: Dementia;   Delirium
Interventions: Drug: Quetiapine 25 mg gel applied topically;   Drug: Quetiapine 25 mg tablet by mouth;   Drug: Quetiapine 25 mg rectal suppository
Outcome Measures: Serum quetiapine levels after topical application (Visit 1);   Serum quetiapine levels after oral administration (Visit 2);   Serum quetiapine levels after rectal administration (Visit 3)
2 Unknown  A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder
Condition: Bipolar Disorder
Intervention: Drug: quetiapine fumarate tablet (Seroquel)
Outcome Measures: The primary efficacy variable for this study is the YMRS total score change from baseline to Day 28 (LOCF).;   To evaluate the effectiveness of quetiapine fumarate;   To evaluate the relationship between the serum brain-derived neurotrophic factor and quetiapine fumarate;   To evaluate the safety and tolerability of quetiapine fumarate
3 Unknown  Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)
Conditions: Abnormal Mental State;   Schizophrenia
Intervention: Drug: Quetiapine(Seroquel-XR) 50~800mg a day
Outcome Measures: California Verbal Learning Test;   verbal & spatial 2-back test, Digit Span, 3-7 CPT, WCST, Rey-CFT, TMT A & B, COWAT, SOPS, PANSS, SAS, PAS, AIHQ, BIS
4 Unknown  Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar Mania
Conditions: Bipolar, Mania;   Utapine;   Seroquel
Interventions: Drug: Utapine;   Drug: Seroquel
Outcome Measure:
5 Recruiting The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
Condition: Major Depressive Disorder
Interventions: Drug: SSRI monotherapy;   Drug: Seroquel XR adjunctive
Outcome Measures: Change from baseline in HDRS scale;   Change from baseline in CGI, BDI, and YMRS scales
6 Unknown  Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia
Condition: Acute Schizophrenia
Interventions: Drug: Quetiapine fumarate;   Drug: Haloperidol
Outcome Measures: The primary objective of this study is to evaluate the efficacy of quetiapine fumarate in improving agitation and aggression symptoms for the schizophrenic patients;   The response rate of quetiapine in improving agitation and aggression symptoms - the efficacy of quetiapine - the safety and tolerability of quetiapine - differences between quetiapine and haloperidol
7 Unknown  Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry
Conditions: Schizophrenia;   Psychosis
Intervention: Drug: Quetiapine XR
Outcome Measures: The primary efficacy variable is the change in aggression between admission and day 8 of treatment with Quetiapine XR as measured by the OAS.;   Measuring psychotic symptomatology change from baseline in BPRS-Total Score in aggressive, psychotic patients managed with Quetiapine XR;   Measuring the incidence of adverse events (including Extrapyramidal symptoms) by the change from baseline in SAS and BAS and subjective reports;   Measuring the incidence of concomitant benzodiazepine and other permitted medication use
8 Unknown  Trial of Quetiapine in Anorexia Nervosa
Condition: Anorexia Nervosa
Intervention: Drug: Quetiapine
Outcome Measures: Primarily we will seek to show that Quetiapine is superior to placebo in terms of reducing core eating disorder symptoms on the Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS) and the Eating Disorders Inventory-2.;   We seek to show that Quetiapine is superior to placebo in reducing anxiety, depression, obsessionality, or weight gain in patients with AN. We also will seek to show that Quetiapine is superior to placebo at reducing positive and negative symptoms.
9 Recruiting Quetiapine Pharmacotherapy for Cannabis Dependence
Condition: Cannabis Dependence
Interventions: Drug: Quetiapine;   Drug: Placebo
Outcome Measures: Marijuana Use;   Marijuana Abstinence;   Urine toxicology;   Marijuana withdrawal symptoms;   Marijuana craving;   Sleep disturbance
10 Unknown  Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XR
Condition: BIPOLAR DISORDER
Intervention: Drug: quetiapine
Outcome Measures: Efficacy of quetiapine as a treatment for acute mania and depression, and of as a manutence treatment.;   Assess the pharmacodynamics of quetiapine by neurotrophins in blood samples.
11 Recruiting Gao Bipolar Spectrum Lithium/Quetiapine Study
Condition: Bipolar Disorder
Interventions: Drug: Lithium;   Drug: Quetiapine
Outcome Measures: Time to study discontinuation;   Lithium vs. Quetiapine effects on general cardiovascular disease risk and role effects on general cardiovascular disease risk and role impairment
12 Not yet recruiting Safety and Tolerability of Quetiapine in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Extended-release quetiapine fumarate
Outcome Measures: Dose-limiting toxicity;   Adverse events
13 Recruiting Post-Traumatic Stress Disorder (PTSD) and Seroquel
Condition: Post-Traumatic Stress Disorder
Intervention: Drug: Seroquel
Outcome Measures: The primary outcome will be the change from baseline in PTSD symptomatology at the week 8 timepoint.;   The secondary outcome will be the change from baseline in PTSD symptomatology at the Week 8 timepoint.
14 Recruiting European Drug Utilization Study
Condition: Major Depressive Disorder (MDD)
Intervention:
Outcome Measures: Patient age (mean and range);   Patient gender (%);   Diagnosis for which Seroquel XR was prescribed (% of Major Depressive Disorder- MDD);   Patients hospitalized for any psychiatric condition (n, %);   Daily dose of Seroquel XR (mode and range);   Patient referral pathway (%);   Participating psychiatrist practice setting (%);   Percent of patients experiencing psychotic symptoms at initiation of Seroquel XR (n, %)
15 Unknown  Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Quetiapine Fumarate Extended Release;   Other: healthy control
Outcome Measures: change from baseline Pittsburgh Quality Index total scores at 4 weeks;   change from baseline Pittsburgh Quality Index total scores at 2 weeks;   change from baseline Pittsburgh Quality Index total scores at 4 days;   change from baseline in sleep architecture measured using polysomnography at 4 weeks;   number of participants with adverse events
16 Recruiting Efficacy of Quetiapine for Pediatric Delirium
Condition: Delirium
Interventions: Drug: quetiapine;   Other: Placebo
Outcome Measures: Time to first resolution of delirium;   Total ICU days with delirium
17 Unknown  Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine
Conditions: Schizophrenia;   Bipolar
Intervention: Drug: Aripiprazole; Quetiapine
Outcome Measure:
18 Recruiting Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
Condition: Delirium
Interventions: Drug: Quetiapine;   Drug: Haloperidol;   Drug: Placebo
Outcome Measures: Time to first resolution of delirium;   Days in delirium during the study;   Duration of delirium;   Severity of delirium (highest Nu-DESC score, mean episode Nu-DESC score);   ICU and hospital mortality;   ICU and hospital length of stay;   Length of mechanical ventilation;   Time spent deeply sedated (RASS <3);   Episodes of subject-initiated device removal;   Use of haloperidol therapy (including total dose in haloperidol equivalents during the study, number of doses, number of days of therapy, use of rescue IV haloperidol);   Average daily and maximum total antipsychotic drug dose in haloperidol equivalents;   Duration of study drug administration;   Use of benzodiazepines;   Use of opioids;   QTc prolongation;   Extrapyramidal symptoms;   Neuroleptic malignant syndrome
19 Recruiting Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
Condition: Bipolar Disorder
Interventions: Drug: Lithium;   Drug: Valproate;   Drug: Oxcarbazepine;   Drug: Quetiapine;   Drug: Olanzapine;   Drug: Ziprasidone
Outcome Measures: Change from baseline in Young Mania Rating Scale at 2 weeks and 6 weeks;   rate of dropout (treatment discontinuation);   Clinical Global Impressions (CGI) Scale;   Brief Psychiatric Rating Scale;   Global Assessment Scale;   Treatment Emergent Symptom Scale;   Hamilton Anxiety Rating Scale;   Hamilton Depression Rating Scale
20 Unknown  Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Insomnia
Intervention: Drug: quetiapine
Outcome Measures: The primary objective is to determine whether quetiapine can increase total sleep time and reduce time awake in patients with AD and sleep disturbance.;   Dose-response relationship of quetiapine and sleep in AD patients?;   Are there sleep architecture changes from quetiapine?;   Do the primary sleep variables change relative to placebo at any weekly time or dose point?;   Are caregivers, blind to treatment status, able to detect changes in sleep quality in the patients for quetiapine relative to placebo?;   Does quetiapine used at single bedtime dosing for potential nighttime soporific effect have a measurable impact on neuropsychiatric symptoms other than insomnia?